Navigation Links
Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms
Date:7/28/2011

tory drugs).

The Phase III study evaluating the efficacy of Jevtana® (cabazitaxel) in first line prostate cancer started enrolling patients during the quarter.

Evolution of the early stage portfolio:Four compounds entered Phase I:

  • SAR125844, a Met Kinase inhibitor in oncology;
  • SAR407899, a RHO Kinase inhibitor for diabetic nephropathy;
  • SAR126119, a TAFIa inhibitor for Acute Ischemic Stroke, back up of SAR104772, currently in Phase I.
  • SAR339658/GBR500, a monoclonal antibody to treat Crohn's Disease and other chronic autoimmune disorders, entered into the portfolio in Phase I with the license agreement signed with Glenmark Pharmaceuticals S.A.

  • Based on negative Phase IIb data, the development of celivarone has been discontinued for the prevention of shocks and major clinical outcomes in patients with implanted cardiac defibrillator.

    Several regulatory milestones were reached during the period for vaccines:

  • In May, the FDA approved the biologics license application for the Fluzone® Intradermal vaccine. Fluzone® Intradermal is indicated for active immunization of adults 18 through 64 years of age against influenza disease caused by influenza virus subtypes A and B contained in the vaccine. Fluzone® Intradermal is the first influenza vaccine licensed in the U.S. that uses a novel microinjection system for intradermal delivery.

  • In July, Sanofi Pasteur started the licensure process of Hexaxim™, the only ready to use 6-in-1 vaccine to protect infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive infections caused by haemophilus influenzae type b. A Common Technical Document (CTD) was submitted to the European Medicine Agency following the "Article 58" procedure for evaluation of medicinal products intended exclusively for markets outside the European Union.

  • Several partnerships were also signed:

  • A
    '/>"/>

  • SOURCE Sanofi
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

    Related medicine technology :

    1. New Senior Executives Appointed at Sanofi:
    2. VR Business Sales, Mergers & Acquisitions Charlotte Completes Sale of Penrod Medical Equipment
    3. Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies
    4. TPI Ships Macrolide API Samples for International Sales Standard Testing
    5. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
    6. Burlington Medical Supplies Reorganizes Sales and Marketing Operations
    7. HASCO Medical Inc. Names Mike Dumais the Vice President of Sales for Southern Medical and Mobility
    8. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
    9. With Launch of New ActiveHome Monitoring System, ActiveCare Announces New Head of Sales and Marketing
    10. TPI Signs Macrolide API International Sales and Marketing Agreement
    11. CellerateRX TV Commercials Begin Airing on Fox News Network via Geraldo at Large and Fox News Sunday Programs, Expanding the Direct-To-Consumer Sales Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
    (Date:7/28/2015)... Ala. , July 28, 2015   Vincari ... for surgeons , has just hired John O,Neil ... Business Development. John has over 30 years of diverse ... roles. Mr. O,Neil,s executive healthcare experience coupled with Vincari,s ... active surgeon allows Vincari to address the challenges both ...
    (Date:7/28/2015)... 2015 The Canadian International Pharmacy ... Canadian Anti-Fraud Centre (CAFC), continues to aggressively ... CIPA verification seal on illegitimate pharmacy websites.  The ... pharmacy member companies who have maintained a 100% ... than 10 million Americans since 2002. ...
    Breaking Medicine Technology:SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3
    ... RA Signs and Symptoms Compared to Placebo, ... (Nasdaq: TRBN ) today announced preliminary ... double-blind, placebo-controlled, multicenter,clinical trial of its TRU-015 ... indicated that Trubion,s TRU-015 product candidate, at,well-tolerated ...
    ... Calif., Sept. 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... antibodies for the treatment of cancer and,hepatitis C ... submitted a,clinical protocol with the Drug Controller General ... safety and efficacy trial of bavituximab in combination,with ...
    Cached Medicine Technology:Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4
    (Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a decision from the Judicial Panel on Multidistrict Litigation (JPML), according to court ... defects research at their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, ...
    (Date:7/29/2015)... Carolina (PRWEB) , ... July 29, 2015 , ... ... MetLife, Inc ., a global provider of life insurance, annuities, employee benefits and ... Challenge North Carolina inclusive sporting event taking place in Charlotte, North Carolina ...
    (Date:7/29/2015)... , ... July 29, 2015 , ... ... the first dermatologist in Sarasota to be chosen by the manufacturer to offer ... offers the first injectable, non-invasive way to treat and eliminate double chin fat,” ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Nature’s Artisan, a new ... of gourmet flavors. , Nature’s Artisan was founded by Tina Yarandi, who came up ... the UCLA School of Dentistry. Tina was amazed when she learned about the incredible ...
    (Date:7/28/2015)... MD (PRWEB) , ... July 28, 2015 , ... Every ... most kids with the disease only experience through movies and television. They go to ... failure of the right side of the heart as it pushes hard to get ...
    Breaking Medicine News(10 mins):Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
    ... of research and billions of dollars, cancer remains a ... the body,s defenses and medical intervention. Now an Arizona ... "Cancer is not a random bunch of selfish rogue ... stress, honed by a long period of evolution," claims ...
    ... in the genome are the cause of many diseases. Gene ... copies offers a means of correcting such defects. Now ... University of Munich, and led by Privatdozent Dr. Carsten Rudolph, ... team shows for the first time that chemical modification of ...
    ... hundreds of proteins produced by the DNA of tumor ... central to a new treatment for the often-fatal childhood ... pediatric clinical trials of a drug that blocks the ... a promising treatment target for high-risk neuroblastoma," said pediatric ...
    ... 7 (HealthDay News) -- Heart attack patients who are exposed ... have an increased risk of cancer, a new study finds. ... a heart attack between April 1996 and March 2006 and ... heart attack, 77 percent of the patients underwent at least ...
    ... News) -- In cold weather, older adults are especially vulnerable ... take steps to prevent this potentially deadly condition. Hypothermia ... remains there for an extended length of time. As people ... of exposure to cold, according to the U.S. National Institute ...
    ... -- The amount of money spent on psychiatric drugs in ... slower rate than in previous years, a new federal government ... psychiatric drugs rose 5.6 percent, compared with an increase of ... Abuse and Mental Health Services Administration. The agency,s analysis ...
    Cached Medicine News:Health News:Conceptualizing cancer cells as ancient 'toolkit' 2Health News:Save messengers -- modified mRNAs open up new therapeutic possibilities 2Health News:Protein may be key to new treatment in a childhood cancer 2Health News:Protein may be key to new treatment in a childhood cancer 3Health News:Heart Scans May Raise Cancer Risk, Study Finds 2Health News:Seniors Vulnerable to Hypothermia 2Health News:U.S. Sees Slowdown in Spending on Mental Health 2
    Ideal for abdominal, hip, thigh and knee procedures....
    Body Suit w/Bra above knee...
    Gynecomastia Vest...
    Male Compression Vest, Front Closure...
    Medicine Products: